David M Kent1, Lester Y Leung2, Yichen Zhou2, Patrick H Luetmer2, David F Kallmes2, Jason Nelson2, Sunyang Fu2, Chengyi Zheng2, Hongfang Liu2, Wansu Chen2. 1. From the Predictive Analytics and Comparative Effectiveness Center (D.M.K., J.N.) and Department of Neurology (L.Y.L.), Tufts Medical Center, Boston, MA; Department of Research and Evaluation (Y.Z., C.Z., W.C.), Kaiser Permanente Southern California, Pasadena; and Department of Radiology (P.H.L., D.F.K.) and Division of Digital Health Services, Department of Health Sciences Research (S.F., H.L.), Mayo Clinic, Rochester, MN. dkent1@tuftsmedicalcenter.org. 2. From the Predictive Analytics and Comparative Effectiveness Center (D.M.K., J.N.) and Department of Neurology (L.Y.L.), Tufts Medical Center, Boston, MA; Department of Research and Evaluation (Y.Z., C.Z., W.C.), Kaiser Permanente Southern California, Pasadena; and Department of Radiology (P.H.L., D.F.K.) and Division of Digital Health Services, Department of Health Sciences Research (S.F., H.L.), Mayo Clinic, Rochester, MN.
Abstract
BACKGROUND AND OBJECTIVES: Silent cerebrovascular disease (SCD), comprising silent brain infarction (SBI) and white matter disease (WMD), is commonly found incidentally on neuroimaging scans obtained in routine clinical care. Their prognostic significance is not known. We aimed to estimate the incidence of and risk increase in future stroke in patients with incidentally discovered SCD. METHODS: Patients in the Kaiser Permanente Southern California (KPSC) health system aged ≥50 years, without prior ischemic stroke, transient ischemic attack (TIA), or dementia/Alzheimer disease receiving a head CT or MRI between 2009 and 2019 were included. SBI and WMD were identified by natural language processing (NLP) from the neuroimage report. RESULTS: Among 262,875 individuals receiving neuroimaging, NLP identified 13,154 (5.0%) with SBI and 78,330 (29.8%) with WMD. The incidence of future stroke was 32.5 (95% confidence interval [CI] 31.1, 33.9) per 1,000 patient-years for patients with SBI: 19.3 (95% CI 18.9, 19.8) for patients with WMD and 6.8 (95% CI 6.7, 7.0) for patients without SCD. The crude hazard ratio (HR) associated with SBI was 3.40 (95% CI 3.25 to 3.56) and for WMD 2.63 (95% CI 2.54 to 2.71). With MRI-discovered SBI, the adjusted HR was 2.95 (95% CI 2.53 to 3.44) for those <65 years of age and 2.15 (95% CI 1.91 to 2.41) for those ≥65. With CT scan, the adjusted HR was 2.48 (95% CI 2.19 to 2.81) for those <65 and 1.81 (95% CI 1.71 to 1.91) for those ≥65. The adjusted HR associated with a finding of WMD was 1.76 (95% CI 1.69 to 1.82) and was not modified by age or imaging modality. DISCUSSION: Incidentally discovered SBI and WMD are common and associated with increased risk of subsequent symptomatic stroke, representing an important opportunity for stroke prevention.
BACKGROUND AND OBJECTIVES: Silent cerebrovascular disease (SCD), comprising silent brain infarction (SBI) and white matter disease (WMD), is commonly found incidentally on neuroimaging scans obtained in routine clinical care. Their prognostic significance is not known. We aimed to estimate the incidence of and risk increase in future stroke in patients with incidentally discovered SCD. METHODS: Patients in the Kaiser Permanente Southern California (KPSC) health system aged ≥50 years, without prior ischemic stroke, transient ischemic attack (TIA), or dementia/Alzheimer disease receiving a head CT or MRI between 2009 and 2019 were included. SBI and WMD were identified by natural language processing (NLP) from the neuroimage report. RESULTS: Among 262,875 individuals receiving neuroimaging, NLP identified 13,154 (5.0%) with SBI and 78,330 (29.8%) with WMD. The incidence of future stroke was 32.5 (95% confidence interval [CI] 31.1, 33.9) per 1,000 patient-years for patients with SBI: 19.3 (95% CI 18.9, 19.8) for patients with WMD and 6.8 (95% CI 6.7, 7.0) for patients without SCD. The crude hazard ratio (HR) associated with SBI was 3.40 (95% CI 3.25 to 3.56) and for WMD 2.63 (95% CI 2.54 to 2.71). With MRI-discovered SBI, the adjusted HR was 2.95 (95% CI 2.53 to 3.44) for those <65 years of age and 2.15 (95% CI 1.91 to 2.41) for those ≥65. With CT scan, the adjusted HR was 2.48 (95% CI 2.19 to 2.81) for those <65 and 1.81 (95% CI 1.71 to 1.91) for those ≥65. The adjusted HR associated with a finding of WMD was 1.76 (95% CI 1.69 to 1.82) and was not modified by age or imaging modality. DISCUSSION: Incidentally discovered SBI and WMD are common and associated with increased risk of subsequent symptomatic stroke, representing an important opportunity for stroke prevention.
Authors: Hans-Christoph Diener; John Eikelboom; Stuart J Connolly; Campbell D Joyner; Robert G Hart; Gregory Y H Lip; Martin O'Donnell; Stefan H Hohnloser; Graeme J Hankey; Olga Shestakovska; Salim Yusuf Journal: Lancet Neurol Date: 2012-02-01 Impact factor: 44.182
Authors: Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas G Altman; Sean Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou Journal: CMAJ Date: 2009-04-16 Impact factor: 8.262
Authors: B Gwen Windham; Bradley Deere; Michael E Griswold; Wanmei Wang; Daniel C Bezerra; Dean Shibata; Kenneth Butler; David Knopman; Rebecca F Gottesman; Gerardo Heiss; Thomas H Mosley Journal: Ann Intern Med Date: 2015-07-07 Impact factor: 25.391
Authors: Corinna Koebnick; Annette M Langer-Gould; Michael K Gould; Chun R Chao; Rajan L Iyer; Ning Smith; Wansu Chen; Steven J Jacobsen Journal: Perm J Date: 2012
Authors: Eric E Smith; Gustavo Saposnik; Geert Jan Biessels; Fergus N Doubal; Myriam Fornage; Philip B Gorelick; Steven M Greenberg; Randall T Higashida; Scott E Kasner; Sudha Seshadri Journal: Stroke Date: 2016-12-15 Impact factor: 10.170
Authors: David M Kent; Lester Y Leung; Eric J Puttock; Andy Y Wang; Patrick H Luetmer; David F Kallmes; Jason Nelson; Sunyang Fu; Chengyi Zheng; Ellen M Vickery; Hongfang Liu; Alastair J Noyce; Wansu Chen Journal: Ann Neurol Date: 2022-08-17 Impact factor: 11.274